EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selected risk factors for mortality in children with HUS – a single-center analysis

Ewelina Jarosz-Wójcik, Mateusz Zajączkowski, Dorota Drożdż, Magdalena Błasiak, Monika Miklaszewska

Advances in Medical Sciences · 2026-09 · 71 (2) · 360-368

DOI: 10.1016/j.advms.2026.10.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences, 2026-09. Verfasst von Ewelina Jarosz-Wójcik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Department of Pediatric Nephrology and …. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniwersytet Jagielloński w Krakowie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The aim of the study was to describe clinical and laboratory characteristics of hemolytic-uremic syndrome (HUS), and identify prognostic factors, including risk factors for mortality and complications. MATERIALS AND METHODS: It is a retrospective study of 74 pediatric patients (69 survivors and 5 non-survivors) with the first episode of HUS who were hospitalized in our tertiary reference center during 10-year period. RESULTS: Compared to survivors, non-survivors significantly more frequently developed neurological symptoms (100% vs. 31.9%), suffered from respiratory tract infections (80% vs. 27.5%), respiratory insufficiency (100% vs. 21.7%), circulatory failure (80% vs. 2.9%), and more often required renal replacement therapy (100% vs. 52.2%). In this group, there was a significant reduction in complement C3c and C4 components (0.67 vs. 0.97, 0.08 vs. 0.18, respectively). Elevated PCT, CRP, D-dimers, APTT, lipase, AST, GGTP and reduced C3c and C4 were associated with increased mortality risk. Severe neurological and ophthalmological complications, as well as circulatory insufficiency were the strongest predictors of death. Overall mortality rate was 6.8%. CONCLUSIONS: Neurological (ischemic stroke, ophthalmological anomalies) and systemic (circulatory failure) complications may represent important determinants of outcome in pediatric HUS. Mortality also appears to be associated with systemic inflammatory activation and coagulopathy.

Schlagwörter

Stichwörter der Autor:innen

Hemolytic uremic syndromeMortalityThrombotic microangiopathies

Autor:innen und Institutionen

  • Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Department of Pediatric Nephrology and Hypertension, University Children's Hospital, Kraków, Poland.
  • Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
  • Department of Pediatric Nephrology and Hypertension, University Children's Hospital, Kraków, Poland; Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
  • Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Kraków, Poland; Department of Pediatric Nephrology and Hypertension, University Children's Hospital, Kraków, Poland. Electron…

Förderung

  • Uniwersytet Jagielloński w Krakowie

Zitieren

APA

Jarosz-Wójcik, E., Zajączkowski, M., Drożdż, D., Błasiak, M., & Miklaszewska, M. (2026). Selected risk factors for mortality in children with HUS – a single-center analysis. Advances in Medical Sciences, 71(2), 360-368. https://doi.org/10.1016/j.advms.2026.10.003

Vancouver

Jarosz-Wójcik E, Zajączkowski M, Drożdż D, Błasiak M, Miklaszewska M. Selected risk factors for mortality in children with HUS – a single-center analysis. Advances in Medical Sciences. 2026;71(2):360-368. doi:10.1016/j.advms.2026.10.003

BibTeX
@article{JaroszWjcik2026,
  author = {Jarosz-Wójcik, Ewelina and Zajączkowski, Mateusz and Drożdż, Dorota and Błasiak, Magdalena and Miklaszewska, Monika},
  title = {Selected risk factors for mortality in children with HUS – a single-center analysis},
  journal = {Advances in Medical Sciences},
  year = {2026},
  volume = {71},
  number = {2},
  pages = {360--368},
  doi = {10.1016/j.advms.2026.10.003}
}
Kostenlos starten →